Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer

BACKGROUND/AIMS: The treatment of epidermal growth factor receptor (EGFR)-mutated lung cancer cases has shown remarkable development in the past two decades. However, there have been limited studies comparing the prognostic effects of EGFR-tyrosine kinase inhibitor (TKI) and other treatment modaliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Seung Hun, Lee, Dong Yoon, Jeong, Jihyeon, Choi, Won-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271728/
https://www.ncbi.nlm.nih.gov/pubmed/35811369
http://dx.doi.org/10.3904/kjim.2021.488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271728/
https://www.ncbi.nlm.nih.gov/pubmed/35811369
http://dx.doi.org/10.3904/kjim.2021.488

Ejemplares similares